• Follow the Money: First Circular RNA-Based Clinical Assay, Oncology Programs, More

    Clinical Research News | Circular Genomics plans to build and scale commercial operations in preparation for the launch of the world's first circular RNA-based clinical assay; NextPoint Therapeutics will advance the company’s two immuno-oncology clinical programs, NPX267 and NPX887; Accent Therapeutics will use funding to support the advancement of both lead programs—Accent’s first-in-class DHX9 inhibitor and a potentially best-in-class KIF18A inhibitor; and more.

    Feb 28, 2024

  • CliniSpan Health Wins SCOPE’s Clinical Trial Tech: Startup Pitch Contest

    Clinical Research News | If artificial intelligence (AI) is to be as insightful as possible in advancing human health, it is not enough to have a patchwork of out-of-context data from which to draw conclusions. That is unfortunately the current situation and at the cost of lost opportunities to better treat patients, identify early biomarkers of disease, and recognize the right endpoints in clinical trials—not to mention eradicating existing biases against marginalized groups of people.

    Feb 27, 2024

  • Convergence of Clinical Research and Clinical Care On The Horizon

    Clinical Research News | If artificial intelligence (AI) is to be as insightful as possible in advancing human health, it is not enough to have a patchwork of out-of-context data from which to draw conclusions. That is unfortunately the current situation and at the cost of lost opportunities to better treat patients, identify early biomarkers of disease, and recognize the right endpoints in clinical trials—not to mention eradicating existing biases against marginalized groups of people.

    Feb 27, 2024

  • ClinEco Commons Launches, Offering Portal for Industry Resources, Expertise

    Clinical Research News | At SCOPE last week, ClinEco launched ClinEco Commons, the latest addition to the growing online community and marketplace designed to be the central resource for clinical research professionals worldwide, offering a comprehensive and easy-to-use portal for critical information and industry expertise.

    Feb 23, 2024